Literature DB >> 7534921

Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release.

M Nisell1, G G Nomikos, T H Svensson.   

Abstract

The present study examined the effects of acute, continuous infusion of nicotine in either the ventral tegmental area or the nucleus accumbens on extracellular concentrations of dopamine in the nucleus accumbens by applying in vivo microdialysis in freely moving rats. Nicotine (1000 microM) infusion for 80 min. in the ventral tegmental area produced a long-lasting increase in accumbal dopamine, whereas similar nicotine infusion in the nucleus accumbens increased dopamine levels only within the first 20 min. of administration. This effect was blocked by systemic pretreatment with the nicotinic receptor antagonist mecamylamine (1 mg/kg, subcutaneously). In contrast to the effects of nicotine, N-methyl-D-aspartate infusion in the ventral tegmental area as well as in the nucleus accumbens produced a long-lasting increase in accumbal dopamine levels. The more procounced effect of infusion of nicotine in the ventral tegmental area as compared to the nucleus accumbens on accumbal dopamine release may be due to a lower rate or even lack of tolerance to nicotine's stimulatory action in the ventral tegmental area. These results support the notion that nicotinic receptors in the ventral tegmental area may be of greater importance than those located in the nucleus accumbens for mediating some of the stimulatory effects of nicotine on the reward-related mesoaccumbens dopamine system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7534921     DOI: 10.1111/j.1600-0773.1994.tb00373.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  52 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

Review 2.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

3.  Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats.

Authors:  Xia Li; Manoranjan S D'Souza; Ana M Niño; James Doherty; Alan Cross; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2016-02-13       Impact factor: 4.530

4.  Reliability of striatal [¹¹C]raclopride binding in smokers wearing transdermal nicotine patches.

Authors:  Karmen K Yoder; Daniel S Albrecht; David A Kareken; Lauren M Federici; Kevin M Perry; Elizabeth A Patton; Qi-Huang Zheng; Bruce H Mock; Sean J O'Connor; Christine M Herring
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-19       Impact factor: 9.236

5.  Aripiprazole therapy for nicotine dependence.

Authors:  Sriram Ramaswamy; Subhash C Bhatia
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

6.  TC-2559 excites dopaminergic neurones in the ventral tegmental area by stimulating alpha4beta2-like nicotinic acetylcholine receptors in anaesthetised rats.

Authors:  Yun Wang; John L Sherwood; Colin P Miles; Gary Whiffin; David Lodge
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

7.  Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study.

Authors:  Britta Hahn; Thomas J Ross; Frank A Wolkenberg; Diaa M Shakleya; Marilyn A Huestis; Elliot A Stein
Journal:  Cereb Cortex       Date:  2008-12-10       Impact factor: 5.357

8.  Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

Authors:  Alexander R Kosowski; Gvido Cebers; Aleta Cebere; Ann-Charlott Swanhagen; Sture Liljequist
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

Review 9.  Tobacco use among individuals with schizophrenia: what role has the tobacco industry played?

Authors:  Judith J Prochaska; Sharon M Hall; Lisa A Bero
Journal:  Schizophr Bull       Date:  2007-11-05       Impact factor: 9.306

Review 10.  Heterogeneity of reward mechanisms.

Authors:  A Lajtha; H Sershen
Journal:  Neurochem Res       Date:  2009-12-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.